Suppr超能文献

日本家族性肌萎缩侧索硬化症的综合靶向新一代测序

Comprehensive targeted next-generation sequencing in Japanese familial amyotrophic lateral sclerosis.

作者信息

Nishiyama Ayumi, Niihori Tetsuya, Warita Hitoshi, Izumi Rumiko, Akiyama Tetsuya, Kato Masaaki, Suzuki Naoki, Aoki Yoko, Aoki Masashi

机构信息

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Medical Genetics, Tohoku University School of Medicine, Sendai, Japan.

Department of Medical Genetics, Tohoku University School of Medicine, Sendai, Japan.

出版信息

Neurobiol Aging. 2017 May;53:194.e1-194.e8. doi: 10.1016/j.neurobiolaging.2017.01.004. Epub 2017 Jan 10.

Abstract

Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease characterized by loss of motor neurons. We have recently identified SOD1 and FUS mutations as the most common causes in a consecutive series of 111 familial ALS pedigrees in Japan. To reveal possible genetic causes for the remaining 51 patients with familial ALS (45 pedigrees), we performed targeted next-generation sequencing of 35 known ALS/motor neuron diseases-related genes. Known variants in ANG, OPTN, SETX, and TARDBP were identified in 6 patients. A novel likely pathogenic homozygous variant in ALS2 was identified in 1 patient. In addition, 18 patients harbored 1-3 novel variants of uncertain significance, whereas hexanucleotide repeat expansions in C9ORF72 were not detected using repeat-primed polymerase chain reaction. Collectively, in our Japanese cohort, the frequencies of SOD1, FUS, SETX, TARDBP, ANG, and OPTN variants were 32%, 11%, 2%, 2%, 1%, and 1%, respectively. These findings indicate considerable differences in the genetic variations associated with familial ALS across populations. Further genetic analyses and functional studies of novel variants are warranted.

摘要

肌萎缩侧索硬化症(ALS)是一种成年发病的神经退行性疾病,其特征为运动神经元丧失。我们最近在日本连续的111个家族性ALS家系中确定,超氧化物歧化酶1(SOD1)和融合蛋白(FUS)突变是最常见的病因。为了揭示其余51例家族性ALS患者(45个家系)可能的遗传病因,我们对35个已知的与ALS/运动神经元疾病相关的基因进行了靶向二代测序。在6例患者中鉴定出血管生成素(ANG)、 optineurin(OPTN)、Senataxin(SETX)和TAR DNA结合蛋白(TARDBP)中的已知变异。在1例患者中鉴定出ALS2基因中的一种新的可能致病的纯合变异。此外,18例患者携带1至3种意义未明的新变异,而使用重复引物聚合酶链反应未检测到C9orf72基因中的六核苷酸重复扩增。总体而言,在我们的日本队列中,SOD1、FUS、SETX、TARDBP、ANG和OPTN变异的频率分别为32%、11%、2%、2%、1%和1%。这些发现表明,不同人群中与家族性ALS相关的基因变异存在显著差异。有必要对新变异进行进一步的遗传分析和功能研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验